Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

June’s top stories: AbbVie’s cancer drug, GSK and Genmab’s leukaemia drug trial

AbbVie started a Phase III clinical trial of veliparib, in combination with carboplatin and paclitaxel, in patients with advanced breast cancer, while GSK and Genmab's Phase III trial of leukaemia drug ofatumumab fails to meet primary endpoint. Drugdevelopment-technology.com wraps-up the key headlines from June 2014.

Go Top